🇺🇸 FDA
Pipeline program

AB-101

AB-101-001

Phase 1 small_molecule completed

Quick answer

AB-101 for Chronic Hepatitis b is a Phase 1 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Arbutus Biopharma Corp
Indication
Chronic Hepatitis b
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials